Big Pharma, fueled by promising pipelines and cost-cutting, is poised for a strong 2008, analysts say, while projections are mixed for the biotech sector.
Read More...
[Source: Financial news of the day - CNNMoney.com]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment